Your logo

Prostate News Archive


  • Biomira Stimuvax(R) (L-BLP25) Prostate Cancer Study Results Published (CNW Group via Yahoo! Finance)

    Biomira Inc. , today announced publication of study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine or L-BLP25, could slow rising prostate Specific Antigen levels in some post-surgical prostate cancer patients, potentially delaying the need for initiation of androgen deprivation therapy .

  • 'Earl the Pearl' still gem of guy to his fans (Baltimore Sun)

    Now shooting for goal of prostate awareness, Monroe recalls Bullets' glory days on stop here Robert Abrams had an effusive greeting for the sharp-dressed man he embraced outside the Men's Health Center on North Avenue yesterday.

  • Biomira's Stimuvax Could Benefit Prostate Cancer Patients (RedNova)

    Biomira has released study results showing that Stimuvax, formerly known as BLP25 Liposome Vaccine, could slow rising prostate specific antigen levels in some post-surgical prostate cancer patients.

  • Analysis: Prostate Drug for Alzheimer's? (RedNova)

    By ED SUSMAN Voyager Pharmaceutical Corp.'s investigational drug -- commonly used to treat prostate cancer -- received mixed results Wednesday from its phase 2 study in the treatment of men and women with mild-to-moderate Alzheimer's disease.

  • Watchful Waiting on Prostate Cancer (KABC-TV Los Angeles)

    The purpose of detecting prostate cancer is to catch it while it's easy to cure. But now some younger patients are chosing not to immediately get the traditional treatment for the disease. And they say it's a scary choice.

  • New diagnostic tool for prostate cancer (News-Medical-Net)

    According to the World Health Organization there are about 250,000 new cases of prostate cancer every year but, when caught in time, the disease has a cure rate of over 90%.

  • Tehachapi News (Tehachapi News)

    An informational meeting regarding prostate cancer will be held on July 27 at 7 p.m. Men and wives are invited to attend. For more information, call 822-5662 or 821-0684.

  • Back to Prostate News Archive